These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 276621)

  • 21. Gangliosides and other lipids of hyperplastic liver nodules induced by N-2-fluorenylacetamide.
    Merritt WD; Keenan TW; Morré JD
    Cancer Biochem Biophys; 1976 May; 1(4):179-85. PubMed ID: 975019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation by butylated hydroxytoluene of liver and bladder carcinogenesis induced by chronic low-level exposure to 2-acetylaminofluorene.
    Williams GM; Tanaka T; Maruyama H; Maeura Y; Weisburger JH; Zang E
    Cancer Res; 1991 Dec; 51(23 Pt 1):6224-30. PubMed ID: 1933882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the peroxisome proliferator di(2-ethylhexyl)phthalate on enzymes in rat liver and on carcinogen-induced liver altered foci in comparison to the promoter phenobarbital.
    Maruyama H; Tanaka T; Williams GM
    Toxicol Pathol; 1990; 18(2):257-67. PubMed ID: 1975953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of low-dose N-2-fluorenylacetamide-induced hyperplastic liver nodules by pre-existing cirrhosis.
    Watanabe A; Yamauchi Y; Kobayashi M; Nagashima H
    Carcinogenesis; 1987 Oct; 8(10):1445-8. PubMed ID: 2888544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated expression and cell cycle deregulation of a mitosis-associated target polypeptide of a carcinogen in hyperplastic and malignant rat hepatocytes.
    Sorof S; Custer RP
    Cancer Res; 1987 Jan; 47(1):210-20. PubMed ID: 3791207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced DNA adduct formation in replicating liver cells during continuous feeding of a chemical carcinogen.
    Huitfeldt HS; Brandtzaeg P; Poirier MC
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5955-8. PubMed ID: 2198576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats.
    Tanaka T; Iwata H; Niwa K; Mori Y; Mori H
    Jpn J Cancer Res; 1988 Dec; 79(12):1297-303. PubMed ID: 2906931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initiation by bleomycin of hepatocellular foci in the rat.
    Kaufmann WK; Zhang Y; Kaufman DG
    Carcinogenesis; 1992 Apr; 13(4):703-7. PubMed ID: 1374296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth of carcinogen-altered rat hepatocytes in the liver of syngeneic recipients promoted with phenobarbital.
    Hanigan MH; Pitot HC
    Cancer Res; 1985 Dec; 45(12 Pt 1):6063-70. PubMed ID: 3904978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical carcinogenesis: persistence of bound forms of 2-fluorenylacetamide.
    Epstein SM; McNary J; Bartus B; Farber E
    Science; 1968 Nov; 162(3856):907-8. PubMed ID: 5684496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfer of viable putative preneoplastic hepatocytes to the livers of syngeneic host rats.
    Laishes BA; Farber E
    J Natl Cancer Inst; 1978 Aug; 61(2):507-12. PubMed ID: 28422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of initiating or promoting activity of six benzodiazepine tranquilizers in rat liver limited bioassays monitored by histopathology and assay of liver and plasma enzymes.
    Remandet B; Gouy D; Berthe J; Mazue G; Williams GM
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 1):152-63. PubMed ID: 6144610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro measurement of resistance to phalloidin and gamma-glutamyltransferase of carcinogen-induced preneoplastic hepatocytes of rats.
    Sawada N; Furukawa K; Tsukada H
    J Natl Cancer Inst; 1982 Sep; 69(3):683-6. PubMed ID: 6125619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous basophilic foci of hepatocellular alteration in Fischer 344 female rats do not exclude iron.
    Stitzel KA; Horn PA; Ezra MF
    Carcinogenesis; 1990 Dec; 11(12):2253-4. PubMed ID: 1702370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concanavalin A agglutination of cells from primary hepatocellular carcinomas and hepatic nodules induced by N-2-fluorenylacetamide.
    Becker FF; Shurgin A
    Cancer Res; 1975 Oct; 35(10):2879-83. PubMed ID: 168971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition by acetaminophen of neoplastic initiation elicited in rat liver by the DNA-reactive hepatocarcinogen N-acetyl-2-aminofluorene.
    Williams GM; Iatropoulos MJ; Jeffrey AM; Duan JD; Perrone CE
    Eur J Cancer Prev; 2007 Dec; 16(6):528-34. PubMed ID: 18090125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced DNA repair response of cells from carcinogen-induced rat liver altered foci exposed to chemical carcinogens in culture.
    Mori H; Sugie S; Ohbayashi F; Shima H; Yoshimi N; Takahashi M; Williams GM
    Carcinogenesis; 1985 Aug; 6(8):1087-90. PubMed ID: 2861918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histochemical correlation between glycogen, nucleic acids and nucleases in pre-neoplastic and neoplastic lesions of rat liver after short-term administration of N-nitrosomorpholine.
    Taper HS; Bannasch P
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Sep; 87(1):53-65. PubMed ID: 185826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration of hepatocytes by subcarcinogenic exposure to n-2-fluorenylacetamide.
    Becker FF
    Cancer Res; 1975 Jul; 35(7):1734-6. PubMed ID: 165882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early histochemical markers of hepatocarcinogenesis].
    Vinarchuk MP; Bykorez AI
    Eksp Onkol; 1984; 6(1):11-6. PubMed ID: 6209085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.